<?xml version="1.0" encoding="UTF-8"?>
<ref id="B227-pharmaceuticals-14-00381">
 <label>227.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ortega</surname>
    <given-names>J.T.</given-names>
   </name>
   <name>
    <surname>Su√°rez</surname>
    <given-names>A.I.</given-names>
   </name>
   <name>
    <surname>Serrano</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Baptista</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Pujol</surname>
    <given-names>F.H.</given-names>
   </name>
   <name>
    <surname>Rangel</surname>
    <given-names>H.R.</given-names>
   </name>
  </person-group>
  <article-title>The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro</article-title>
  <source>AIDS Res. Ther.</source>
  <year>2017</year>
  <volume>14</volume>
  <fpage>57</fpage>
  <pub-id pub-id-type="doi">10.1186/s12981-017-0183-6</pub-id>
  <pub-id pub-id-type="pmid">29025433</pub-id>
 </element-citation>
</ref>
